Deuterated 4 -oxoquinoline derivatives for the treatment of HIV infection

Details for Australian Patent Application No. 2008299931 (hide)

Owner CONCERT PHARMACEUTICALS, INC.

Inventors Harbeson, Scott L.

Agent Spruson & Ferguson

Pub. Number AU-A-2008299931

PCT Pub. Number WO2009/035662

Priority 60/993,428 12.09.07 US

Filing date 12 September 2008

Wipo publication date 19 March 2009

International Classifications

C07D 215/56 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 31/47 (2006.01) - Quinolines

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

6 May 2010 PCT application entered the National Phase

  PCT publication WO2009/035662 Priority application(s): WO2009/035662

17 June 2010 Alteration of Name

  The name of the applicant has been altered to CoNCERT Pharmaceuticals, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008299938-Optical device components

2008299921-Synthesis of deuterated catechols and benzo[d][1,3] dioxoles and derivatives thereof